What does Federal Law No. (8) of 2019 on Medical Products, Pharmacy Profession and Pharmaceutical Establishments 23 state regarding the progress of clinical study phases?
Federal Law No. (8) of 2019 on Medical Products, Pharmacy Profession and Pharmaceutical Establishments 23 states that the progress of clinical study phases should be approved based on the number of volunteers participating in the study.